GB Patent

GB1183940A — Ferric Hydroxide Complexes

Assigned to Fisons Pharmaceuticals Ltd · Expires 1970-03-11 · 56y expired

What this patent protects

1,183,940. Medicines comprising complexed iron. FISONS PHARMACEUTICALS Ltd. 5 Oct., 1967 [22 Oct., 1966; 21 Dec., 1966; 16 Aug., 1967], Nos. 47466/66, 57323/66 and 37691/67. Heading A5B. [Also in Division C3] A pharmaceutical or veterinary composition comprises an aqueous colloid…

USPTO Abstract

1,183,940. Medicines comprising complexed iron. FISONS PHARMACEUTICALS Ltd. 5 Oct., 1967 [22 Oct., 1966; 21 Dec., 1966; 16 Aug., 1967], Nos. 47466/66, 57323/66 and 37691/67. Heading A5B. [Also in Division C3] A pharmaceutical or veterinary composition comprises an aqueous colloidal suspension of a complex of Fe(OH) 3 with either dextrin heptonic acid or dextran heptonic acid (see Division C3). The composition is suitable for intravenous injection; may have an average I.V. at 25‹C of 0.025-0.25; and may also contain vitamin B 12 and/or folic acid.

Drugs covered by this patent

Patent Metadata

Patent number
GB1183940A
Jurisdiction
GB
Classification
—
Expires
1970-03-11
Drug substance claim
No
Drug product claim
No
Assignee
Fisons Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.